These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35405102)

  • 1. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
    Eneanya OA; Gankpala L; Goss CW; Momolu AT; Nyan ES; Gray EB; Fischer K; Curtis K; Bolay FK; Weil GJ; Fischer PU
    Acta Trop; 2022 Jul; 231():106437. PubMed ID: 35405102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Annual versus Semiannual Mass Drug Administration with Ivermectin and Albendazole on Helminth Infections in Southeastern Liberia.
    Eneanya OA; Gankpala L; Goss CW; Bolay FK; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2021 Nov; 106(2):700-709. PubMed ID: 34814104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
    Pion SDS; Chesnais CB; Awaca-Uvon NP; Vlaminck J; Abdou A; Kunyu-Shako B; Kuyangisa Simuna G; Tambwe JP; Weil GJ; Boussinesq M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008322. PubMed ID: 32574160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.
    Pion SD; Chesnais CB; Bopda J; Louya F; Fischer PU; Majewski AC; Weil GJ; Boussinesq M; Missamou F
    Am J Trop Med Hyg; 2015 May; 92(5):959-66. PubMed ID: 25758650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.
    Supali T; Djuardi Y; Lomiga A; Nur Linda S; Iskandar E; Goss CW; Miller JP; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2019 Feb; 100(2):336-343. PubMed ID: 30560772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections.
    Campillo JT; Awaca-Uvon NP; Tambwe JP; Kuyangisa-Simuna G; Vlaminck J; Weil GJ; Boussinesq M; Chesnais CB; Pion SDS
    Parasit Vectors; 2021 Jun; 14(1):310. PubMed ID: 34103096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania.
    Massa K; Magnussen P; Sheshe A; Ntakamulenga R; Ndawi B; Olsen A
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):25-30. PubMed ID: 18771788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
    Chami GF; Kabatereine NB; Tukahebwa EM
    BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
    Mohammed KA; Haji HJ; Gabrielli AF; Mubila L; Biswas G; Chitsulo L; Bradley MH; Engels D; Savioli L; Molyneux DH
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e171. PubMed ID: 18235853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
    Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M
    Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
    Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
    Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
    Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ivermectin mass drug administration on burden of soil-transmitted helminths in onchocerciasis control and elimination programs, Yeki district, southwest Ethiopia.
    Gebrezgabiher G; Yewhalaw D; Ayana M; Hailu A; Mekonnen Z
    PLoS One; 2022; 17(2):e0263625. PubMed ID: 35143567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
    Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
    PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
    Anagbogu IN; Saka YA; Surakat OA; Okoronkwo C; Davies E; Oyale P; Ekpo UF; Amazigo UV; Barbre K; Igbe M; Nyior A; Jacob SM; Gideon Nteun U; Abubakar Umar Z
    Parasit Vectors; 2022 Jun; 15(1):201. PubMed ID: 35698164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.